Cordis appeals $40M award to Boston Sci

Patent disputes involving big names can involve big settlements. And a decision in favor of Boston Scientific ($BSX) over Johnson & Johnson ($JNJ) unit Cordis is no exception. Natick, MA-based Boston Sci scored a cool $40 million ruling last month in its favor against Cordis--twice what a jury awarded it in May 2011. But Cordis has filed an appeal with the U.S. Court of Appeals for the Federal Circuit in Washington. Item


Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.